Press Releases

News Brief

Samsung Biologics signs MOU with Korean Labor Ministry to foster workplace safety

 

Samsung Biologics signs MOU with Korean Labor Ministry to foster workplace safety

Samsung Biologics held a signing ceremony at its Songdo headquarters with the Korean Ministry of Employment and Labor to formalize its shared goal in promoting a safe workplace.

 

Upon the signing of the MOU, the Labor Ministry will utilize Samsung Biologics’ safety programs as best practices to implement in the industry, while the company remains dedicated to creating a positive working environment through its safety protocols and campaigns. Last month, Samsung Biologics also signed MOUs with 22 partner companies for enhanced safety awareness in the workplace.

 

As a sustainable CDMO partner, we will take the lead in strengthening and cultivating a healthy and safe culture within the biopharma industry,” said Kun Lo, Executive Vice President of Engineering, Procurement, Construction & Validation (EPCV) at Samsung Biologics.

 

Samsung Biologics signs MOU with Korean Labor Ministry to foster workplace safety

Samsung Biologics held a signing ceremony at its Songdo headquarters with the Korean Ministry of Employment and Labor to formalize its shared goal in promoting a safe workplace.

 

Upon the signing of the MOU, the Labor Ministry will utilize Samsung Biologics’ safety programs as best practices to implement in the industry, while the company remains dedicated to creating a positive working environment through its safety protocols and campaigns. Last month, Samsung Biologics also signed MOUs with 22 partner companies for enhanced safety awareness in the workplace.

 

As a sustainable CDMO partner, we will take the lead in strengthening and cultivating a healthy and safe culture within the biopharma industry,” said Kun Lo, Executive Vice President of Engineering, Procurement, Construction & Validation (EPCV) at Samsung Biologics.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION